| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium channel activity | 1.39e-06 | 52 | 32 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 7.46e-06 | 3 | 32 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.43e-05 | 93 | 32 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 2.48e-05 | 5 | 32 | 2 | GO:0098640 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 3.72e-05 | 6 | 32 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 5.20e-05 | 7 | 32 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 8.89e-05 | 9 | 32 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.55e-04 | 171 | 32 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.24e-04 | 14 | 32 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.33e-04 | 17 | 32 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 3.75e-04 | 18 | 32 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.72e-04 | 24 | 32 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 7.89e-04 | 26 | 32 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 8.52e-04 | 27 | 32 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.14e-03 | 129 | 32 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.27e-03 | 33 | 32 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.79e-03 | 151 | 32 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.91e-03 | 334 | 32 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.10e-03 | 343 | 32 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.16e-03 | 43 | 32 | 2 | GO:0005231 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.46e-03 | 46 | 32 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.76e-03 | 57 | 32 | 2 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.16e-03 | 60 | 32 | 2 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.86e-03 | 65 | 32 | 2 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.86e-03 | 65 | 32 | 2 | GO:0022824 | |
| GeneOntologyMolecularFunction | coreceptor activity | 5.93e-03 | 72 | 32 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.95e-03 | 459 | 32 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | chromatin binding | 6.02e-03 | 739 | 32 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | amino acid binding | 6.09e-03 | 73 | 32 | 2 | GO:0016597 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.23e-03 | 465 | 32 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 6.42e-03 | 75 | 32 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 6.59e-03 | 76 | 32 | 2 | GO:0098631 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 6.75e-03 | 77 | 32 | 2 | GO:0005230 | |
| GeneOntologyMolecularFunction | channel activity | 9.48e-03 | 525 | 32 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 9.54e-03 | 526 | 32 | 4 | GO:0022803 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.16e-08 | 29 | 31 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 2.30e-05 | 235 | 31 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | dendrite | 2.65e-05 | 858 | 31 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 2.70e-05 | 860 | 31 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 3.18e-05 | 6 | 31 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.29e-05 | 46 | 31 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | asymmetric synapse | 6.20e-05 | 477 | 31 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynapse | 8.91e-05 | 1018 | 31 | 8 | GO:0098794 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.03e-04 | 523 | 31 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.71e-04 | 73 | 31 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.17e-04 | 378 | 31 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.85e-04 | 17 | 31 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 3.25e-04 | 1228 | 31 | 8 | GO:0036477 | |
| GeneOntologyCellularComponent | postsynaptic density | 4.89e-04 | 451 | 31 | 5 | GO:0014069 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 8.01e-04 | 503 | 31 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 9.06e-04 | 785 | 31 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 9.54e-04 | 523 | 31 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.19e-03 | 550 | 31 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.55e-03 | 583 | 31 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | presynapse | 1.69e-03 | 886 | 31 | 6 | GO:0098793 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.03e-03 | 45 | 31 | 2 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.49e-03 | 50 | 31 | 2 | GO:0098878 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.89e-03 | 405 | 31 | 4 | GO:0045211 | |
| GeneOntologyCellularComponent | axon terminus | 3.65e-03 | 210 | 31 | 3 | GO:0043679 | |
| GeneOntologyCellularComponent | neuron projection terminus | 4.88e-03 | 233 | 31 | 3 | GO:0044306 | |
| GeneOntologyCellularComponent | dendritic spine | 5.42e-03 | 242 | 31 | 3 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 5.74e-03 | 247 | 31 | 3 | GO:0044309 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 6.58e-03 | 817 | 31 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | neuronal cell body | 7.20e-03 | 835 | 31 | 5 | GO:0043025 | |
| GeneOntologyCellularComponent | presynaptic membrane | 7.87e-03 | 277 | 31 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | terminal bouton | 8.90e-03 | 96 | 31 | 2 | GO:0043195 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.04e-02 | 104 | 31 | 2 | GO:0034705 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.09e-02 | 591 | 31 | 4 | GO:0005911 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.10e-02 | 107 | 31 | 2 | GO:0060076 | |
| GeneOntologyCellularComponent | cell body | 1.11e-02 | 929 | 31 | 5 | GO:0044297 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.13e-02 | 317 | 31 | 3 | GO:0032838 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 1.16e-02 | 110 | 31 | 2 | GO:0120111 | |
| GeneOntologyCellularComponent | actomyosin | 1.30e-02 | 117 | 31 | 2 | GO:0042641 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.48e-02 | 350 | 31 | 3 | GO:0098802 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.59e-02 | 360 | 31 | 3 | GO:0099568 | |
| Domain | SPAR_C | 8.52e-06 | 3 | 32 | 2 | PF11881 | |
| Domain | SIPA1L_C | 8.52e-06 | 3 | 32 | 2 | IPR021818 | |
| Domain | VDCC_T_a1 | 8.52e-06 | 3 | 32 | 2 | IPR005445 | |
| Domain | Rap_GAP | 1.27e-04 | 10 | 32 | 2 | PF02145 | |
| Domain | VDCCAlpha1 | 1.27e-04 | 10 | 32 | 2 | IPR002077 | |
| Domain | Rap_GAP_dom | 1.55e-04 | 11 | 32 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.55e-04 | 11 | 32 | 2 | PS50085 | |
| Domain | Iontro_rcpt | 4.28e-04 | 18 | 32 | 2 | IPR001320 | |
| Domain | Lig_chan | 4.28e-04 | 18 | 32 | 2 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 4.28e-04 | 18 | 32 | 2 | PF10613 | |
| Domain | PBPe | 4.28e-04 | 18 | 32 | 2 | SM00079 | |
| Domain | Iono_rcpt_met | 4.28e-04 | 18 | 32 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 4.28e-04 | 18 | 32 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 4.28e-04 | 18 | 32 | 2 | SM00918 | |
| Domain | DAG/PE-bd | 5.85e-04 | 21 | 32 | 2 | IPR020454 | |
| Domain | Pkinase_C | 1.82e-03 | 37 | 32 | 2 | IPR017892 | |
| Domain | ANF_receptor | 1.82e-03 | 37 | 32 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 1.82e-03 | 37 | 32 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 2.03e-03 | 39 | 32 | 2 | IPR028082 | |
| Domain | Pkinase_C | 2.35e-03 | 42 | 32 | 2 | PF00433 | |
| Domain | AGC-kinase_C | 4.13e-03 | 56 | 32 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.13e-03 | 56 | 32 | 2 | PS51285 | |
| Domain | S_TK_X | 4.13e-03 | 56 | 32 | 2 | SM00133 | |
| Domain | Channel_four-helix_dom | 4.28e-03 | 57 | 32 | 2 | IPR027359 | |
| Domain | - | 4.28e-03 | 57 | 32 | 2 | 1.20.120.350 | |
| Domain | C1_1 | 4.28e-03 | 57 | 32 | 2 | PF00130 | |
| Domain | EGF_extracell | 4.73e-03 | 60 | 32 | 2 | IPR013111 | |
| Domain | EGF_2 | 4.73e-03 | 60 | 32 | 2 | PF07974 | |
| Domain | ZF_DAG_PE_1 | 5.37e-03 | 64 | 32 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 5.37e-03 | 64 | 32 | 2 | PS50081 | |
| Domain | C1 | 5.53e-03 | 65 | 32 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 5.70e-03 | 66 | 32 | 2 | IPR002219 | |
| Domain | - | 7.11e-03 | 74 | 32 | 2 | 3.40.50.410 | |
| Domain | VWFA | 8.67e-03 | 82 | 32 | 2 | PS50234 | |
| Domain | VWA | 9.08e-03 | 84 | 32 | 2 | SM00327 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.14e-04 | 10 | 23 | 2 | M10272 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 1.66e-04 | 12 | 23 | 2 | MM15142 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 12947409 | ||
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 8.20e-07 | 2 | 32 | 2 | 15537878 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 15673679 | ||
| Pubmed | Subunit composition of kainate receptors in hippocampal interneurons. | 8.20e-07 | 2 | 32 | 2 | 11144357 | |
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 8.20e-07 | 2 | 32 | 2 | 12808460 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 25043179 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11182092 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 8.20e-07 | 2 | 32 | 2 | 15928066 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 25071191 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 15358807 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 14724198 | ||
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 8.20e-07 | 2 | 32 | 2 | 8700852 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 15539395 | ||
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 8.20e-07 | 2 | 32 | 2 | 24760837 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 26364583 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 36786913 | ||
| Pubmed | A mosaic of functional kainate receptors in hippocampal interneurons. | 8.20e-07 | 2 | 32 | 2 | 15483117 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 8.20e-07 | 2 | 32 | 2 | 11985817 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 7696618 | ||
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 8.20e-07 | 2 | 32 | 2 | 16221857 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16219388 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 8.20e-07 | 2 | 32 | 2 | 8260617 | |
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 8.20e-07 | 2 | 32 | 2 | 15014126 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11069933 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 31513786 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 15509753 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 2.46e-06 | 3 | 32 | 2 | 23488970 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 26488564 | ||
| Pubmed | Differential trafficking of GluR7 kainate receptor subunit splice variants. | 2.46e-06 | 3 | 32 | 2 | 15805114 | |
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 2.46e-06 | 3 | 32 | 2 | 18591418 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 2.46e-06 | 3 | 32 | 2 | 11230107 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 11897840 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 28846697 | ||
| Pubmed | Distinct Subunit Domains Govern Synaptic Stability and Specificity of the Kainate Receptor. | 2.46e-06 | 3 | 32 | 2 | 27346345 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 1379666 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 8730589 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 2.46e-06 | 3 | 32 | 2 | 28972185 | |
| Pubmed | RapGAPs in brain: multipurpose players in neuronal Rap signalling. | 2.46e-06 | 3 | 32 | 2 | 20576033 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 11927664 | ||
| Pubmed | RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. | 2.46e-06 | 3 | 32 | 2 | 7523595 | |
| Pubmed | Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. | 2.46e-06 | 3 | 32 | 2 | 9880586 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 17650106 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 26277340 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 15513934 | ||
| Pubmed | Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. | 4.92e-06 | 4 | 32 | 2 | 20081851 | |
| Pubmed | Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice. | 4.92e-06 | 4 | 32 | 2 | 30241548 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 16354929 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 4.92e-06 | 4 | 32 | 2 | 28165634 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 19369569 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 25556835 | ||
| Pubmed | The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1. | 4.92e-06 | 4 | 32 | 2 | 35802072 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 17174564 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1H ANKMY1 GRIK1 GRIK2 KIF1A ITGB1 CDC42BPB GLI2 SIPA1L3 | 5.41e-06 | 1489 | 32 | 9 | 28611215 |
| Pubmed | Developmental expression patterns of kainate receptors in the mouse spinal cord. | 8.19e-06 | 5 | 32 | 2 | 23076118 | |
| Pubmed | Kainate receptors: pharmacology, function and therapeutic potential. | 8.19e-06 | 5 | 32 | 2 | 18793656 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 28228252 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 12223554 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 8.19e-06 | 5 | 32 | 2 | 1717158 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 28854365 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 22654117 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 18358623 | ||
| Pubmed | Development of laminar distributions of kainate receptors in the somatosensory cortex of mice. | 8.19e-06 | 5 | 32 | 2 | 9593973 | |
| Pubmed | Preferential assembly of heteromeric kainate and AMPA receptor amino terminal domains. | 8.19e-06 | 5 | 32 | 2 | 29058671 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 12597860 | ||
| Pubmed | N-glycan content modulates kainate receptor functional properties. | 1.23e-05 | 6 | 32 | 2 | 28714086 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 20359526 | ||
| Pubmed | Delayed cortical development in mice with a neural specific deletion of β1 integrin. | 1.23e-05 | 6 | 32 | 2 | 37250402 | |
| Pubmed | Neto1 is an auxiliary subunit of native synaptic kainate receptors. | 1.23e-05 | 6 | 32 | 2 | 21734292 | |
| Pubmed | 1.40e-05 | 160 | 32 | 4 | 31678930 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 17428973 | ||
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 1.72e-05 | 7 | 32 | 2 | 9016303 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 19342380 | ||
| Pubmed | Glutamate receptors: brain function and signal transduction. | 1.72e-05 | 7 | 32 | 2 | 9651535 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 1310861 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.82e-05 | 171 | 32 | 4 | 20201926 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 28330839 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 34478646 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 2.29e-05 | 8 | 32 | 2 | 8163463 | |
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 2.29e-05 | 8 | 32 | 2 | 12761855 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 34100982 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 16382099 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.94e-05 | 9 | 32 | 2 | 9051806 | |
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 24778262 | ||
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 11891216 | ||
| Pubmed | Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. | 6.36e-05 | 13 | 32 | 2 | 18641643 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 6.36e-05 | 13 | 32 | 2 | 20859245 | |
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 19783738 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 25556833 | ||
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 30250269 | ||
| Pubmed | Cooperative activity of noggin and gremlin 1 in axial skeleton development. | 1.39e-04 | 19 | 32 | 2 | 21303853 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.76e-04 | 118 | 32 | 3 | 27377895 | |
| Pubmed | Identification of Modifier Genes in a Mouse Model of Gaucher Disease. | 1.87e-04 | 22 | 32 | 2 | 27568557 | |
| Pubmed | 1.94e-04 | 122 | 32 | 3 | 30773093 | ||
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 8464923 | ||
| Pubmed | 2.17e-04 | 963 | 32 | 6 | 28671696 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 2.24e-04 | 24 | 32 | 2 | 35746896 | |
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 22534482 | ||
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 26387942 | ||
| Pubmed | Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. | 3.28e-04 | 29 | 32 | 2 | 23708969 | |
| Cytoband | 2q37.3 | 1.33e-03 | 77 | 32 | 2 | 2q37.3 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 1.54e-05 | 5 | 23 | 2 | 1199 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.94e-04 | 26 | 23 | 2 | 253 | |
| GeneFamily | PDZ domain containing | 1.58e-02 | 152 | 23 | 2 | 1220 | |
| Coexpression | GSE6681_DELETED_FOXP3_VS_WT_TREG_UP | 4.09e-06 | 199 | 32 | 5 | M6777 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 4.21e-05 | 160 | 32 | 4 | M9111 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_MONOCYTE_UP | 9.44e-05 | 197 | 32 | 4 | M4466 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_DC_UP | 9.81e-05 | 199 | 32 | 4 | M4464 | |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 9.81e-05 | 199 | 32 | 4 | M5357 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.00e-04 | 200 | 32 | 4 | M9496 | |
| Coexpression | GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN | 1.00e-04 | 200 | 32 | 4 | M3513 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP | 1.37e-04 | 82 | 32 | 3 | M18227 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-07 | 191 | 32 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.76e-06 | 157 | 32 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2_(Retrosplenial_cortex_(RSG)/Subiculum/Parasubiculum)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.53e-06 | 48 | 32 | 3 | e96a608c2239f2ceb07d0a492289b24fabf190a1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2_(Retrosplenial_cortex_(RSG)/Subiculum/Parasubiculum)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.53e-06 | 48 | 32 | 3 | 17cb229b199c49ec74d2230b1f8dbb0195b1bf01 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2_(Retrosplenial_cortex_(RSG)/Subiculum/Parasubiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.53e-06 | 48 | 32 | 3 | c030dfb7c3289df7f34e91f31be6e9b47ca045f5 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.36e-06 | 169 | 32 | 4 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.32e-06 | 57 | 32 | 3 | 9614fe2acc6ee039383504f94bbe6d35aac27f25 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.32e-06 | 57 | 32 | 3 | 3c55a5598a7ea789500f2fbd35c79d2b97a3fc7d | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.32e-06 | 57 | 32 | 3 | 309b3d48bfe215d7b581722c06d444b5b2ef6a30 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.49e-06 | 187 | 32 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.03e-05 | 191 | 32 | 4 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.19e-05 | 198 | 32 | 4 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.89e-05 | 121 | 32 | 3 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.79e-05 | 125 | 32 | 3 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 130 | 32 | 3 | e5acaa9aaa22b10d11410e2c01647b31354c21ed | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 138 | 32 | 3 | d5342383c5e52b92c39d7afe76560501be3ea5cd | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 138 | 32 | 3 | e2659949944bdf39b23c7275e380a7a937e2726c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 145 | 32 | 3 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 147 | 32 | 3 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.61e-04 | 148 | 32 | 3 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 1.61e-04 | 148 | 32 | 3 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 150 | 32 | 3 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 150 | 32 | 3 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 152 | 32 | 3 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 152 | 32 | 3 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.92e-04 | 157 | 32 | 3 | f3b4cde52423246ae6fc4924cd1ee502cf6c009c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-04 | 158 | 32 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | COPD-Epithelial-PNEC|COPD / Disease state, Lineage and Cell class | 1.99e-04 | 159 | 32 | 3 | 6018124980c55190928409f3bf41d846a118954a | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.99e-04 | 159 | 32 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | COPD-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 2.03e-04 | 160 | 32 | 3 | cdea93317b0ebb801ddbe73bca6149ce2c727f16 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Cajal-Retzius|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.10e-04 | 162 | 32 | 3 | 1f589a763f3fd4e1e612809ef3903879d47dc1d8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 162 | 32 | 3 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 162 | 32 | 3 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.14e-04 | 163 | 32 | 3 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | -Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.18e-04 | 164 | 32 | 3 | 2d65f025f921a5327bfd8d260815baaed00ef3fa | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 166 | 32 | 3 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-04 | 167 | 32 | 3 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 167 | 32 | 3 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 167 | 32 | 3 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 2.30e-04 | 167 | 32 | 3 | 7ff186b2bed3b0de93addb3b0ae5a2c6e44ddfb2 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-04 | 167 | 32 | 3 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.38e-04 | 169 | 32 | 3 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.38e-04 | 169 | 32 | 3 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 169 | 32 | 3 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-04 | 169 | 32 | 3 | 01a24a8817628125bd004b2be68ffa62c7111f6e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-04 | 171 | 32 | 3 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-04 | 171 | 32 | 3 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 171 | 32 | 3 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 174 | 32 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 174 | 32 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.64e-04 | 175 | 32 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-04 | 175 | 32 | 3 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.64e-04 | 175 | 32 | 3 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.64e-04 | 175 | 32 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 176 | 32 | 3 | eea554ea75580f8dd5fefb57e7f33441ab86b884 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 176 | 32 | 3 | d5cee483d2a60f82fdc67ad447b589d022fe8c97 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.78e-04 | 178 | 32 | 3 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-04 | 178 | 32 | 3 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.82e-04 | 179 | 32 | 3 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 179 | 32 | 3 | f93e81a3fd94adedb24a9db4ac1d53e275bbf8b5 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 179 | 32 | 3 | 878b15ea62e3405682a538f79f58d74b9cd3f398 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 179 | 32 | 3 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 180 | 32 | 3 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 180 | 32 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 180 | 32 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 180 | 32 | 3 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-04 | 181 | 32 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 2.91e-04 | 181 | 32 | 3 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 182 | 32 | 3 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 183 | 32 | 3 | 8820cfed27b292bc0bc9cde4005219ed41900552 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 183 | 32 | 3 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-04 | 183 | 32 | 3 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|lymphoid / Lineage, cell class and subclass | 3.06e-04 | 184 | 32 | 3 | 62a3918705a3fcf3ef25c9ceb80f575a2e56ef76 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 184 | 32 | 3 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | Control-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 3.11e-04 | 185 | 32 | 3 | 520795866d44def5be3910ce8e728045c716a24d | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 3.16e-04 | 186 | 32 | 3 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | d8d559daff4aeef334d403fde4e3ee2e4a6086d0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 187 | 32 | 3 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 187 | 32 | 3 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.21e-04 | 187 | 32 | 3 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 187 | 32 | 3 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | a0bd2b0ec9e73521c245037b1dd51ff8cf24cbf5 | |
| ToppCell | PCW_05-06-Neuronal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 187 | 32 | 3 | 03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 187 | 32 | 3 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-04 | 187 | 32 | 3 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | f2af79a20438108c814a73f9e24cd986d537237f | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-04 | 188 | 32 | 3 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.31e-04 | 189 | 32 | 3 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.36e-04 | 190 | 32 | 3 | 13dc3a0aaa554f63eabac37726bd1f11b66fb3dd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 190 | 32 | 3 | ff3dec5b45c6ea9b5319fb51a0198c6773b7be26 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.36e-04 | 190 | 32 | 3 | ce049630ed69d31f00acbc1b5b0896efc592121f | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.36e-04 | 190 | 32 | 3 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.36e-04 | 190 | 32 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| Drug | 5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime | 1.91e-06 | 2 | 32 | 2 | ctd:C084273 | |
| Drug | LY382884 | 2.41e-06 | 19 | 32 | 3 | CID000656723 | |
| Drug | NS 102 | 3.81e-06 | 22 | 32 | 3 | CID005282252 | |
| Drug | compound 30 | 3.81e-06 | 22 | 32 | 3 | CID005492232 | |
| Drug | SureCN2398996 | 5.74e-06 | 3 | 32 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 5.74e-06 | 3 | 32 | 2 | CID000092154 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 5.74e-06 | 3 | 32 | 2 | CID010679219 | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 7.49e-06 | 196 | 32 | 5 | 4100_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 8.26e-06 | 200 | 32 | 5 | 3222_UP | |
| Drug | LY293558 | 9.98e-06 | 30 | 32 | 3 | CID000127894 | |
| Drug | caffeine | 1.06e-05 | 562 | 32 | 7 | CID000002519 | |
| Drug | 4-methylglutamic acid | 1.10e-05 | 31 | 32 | 3 | CID000005365 | |
| Drug | methsuximide | 1.15e-05 | 4 | 32 | 2 | CID000006476 | |
| Drug | AC1O7G5C | 1.91e-05 | 5 | 32 | 2 | CID006603942 | |
| Drug | phensuximide | 1.91e-05 | 5 | 32 | 2 | CID000006839 | |
| Drug | Flunarizine | 1.91e-05 | 5 | 32 | 2 | DB04841 | |
| Drug | AC1MQ5W8 | 2.86e-05 | 6 | 32 | 2 | CID003396482 | |
| Drug | cerebrocrast | 2.86e-05 | 6 | 32 | 2 | CID000159556 | |
| Drug | 3,4-dihydroquinazoline | 2.86e-05 | 6 | 32 | 2 | CID000583065 | |
| Drug | philanthotoxin | 3.44e-05 | 45 | 32 | 3 | CID000115201 | |
| Drug | LY215840 | 4.00e-05 | 7 | 32 | 2 | CID000132049 | |
| Drug | losigamone | 4.00e-05 | 7 | 32 | 2 | CID000060572 | |
| Drug | AC1L1B65 | 5.33e-05 | 8 | 32 | 2 | CID000001300 | |
| Drug | Cinnarizine | 6.85e-05 | 9 | 32 | 2 | DB00568 | |
| Drug | 1m5b | 6.85e-05 | 9 | 32 | 2 | CID000447081 | |
| Drug | LY339434 | 6.85e-05 | 9 | 32 | 2 | CID006324635 | |
| Drug | NS3763 | 6.85e-05 | 9 | 32 | 2 | CID004359312 | |
| Drug | Landel | 6.85e-05 | 9 | 32 | 2 | CID000163838 | |
| Drug | Colforsin | 7.28e-05 | 315 | 32 | 5 | ctd:D005576 | |
| Drug | GYKI 52466 | 7.38e-05 | 58 | 32 | 3 | CID000003538 | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; HL60; HT_HG-U133A | 8.36e-05 | 166 | 32 | 4 | 2446_UP | |
| Drug | ZD7288 | 8.55e-05 | 10 | 32 | 2 | CID000123983 | |
| Drug | Benzoates | 8.55e-05 | 10 | 32 | 2 | ctd:D001565 | |
| Drug | riluzole | 1.00e-04 | 174 | 32 | 4 | CID000005070 | |
| Drug | Mibefradil | 1.04e-04 | 11 | 32 | 2 | DB01388 | |
| Drug | EBNs | 1.04e-04 | 11 | 32 | 2 | CID000150695 | |
| Drug | arachidonoylglycine | 1.04e-04 | 11 | 32 | 2 | CID000004345 | |
| Drug | AC1L2VU3 | 1.25e-04 | 12 | 32 | 2 | CID000129572 | |
| Drug | themisone | 1.25e-04 | 12 | 32 | 2 | CID000016235 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | 1.33e-04 | 577 | 32 | 6 | CID000000295 | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.44e-04 | 191 | 32 | 4 | 7417_UP | |
| Drug | tetralol | 1.48e-04 | 13 | 32 | 2 | CID000010747 | |
| Drug | Mibefradil | 1.48e-04 | 13 | 32 | 2 | ctd:D020748 | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 6467_DN | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 3316_DN | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 3366_UP | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 4312_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 2426_UP | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; HL60; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 3029_UP | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 7124_DN | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 4574_DN | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 4407_UP | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 4702_DN | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 2306_DN | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 6383_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 2712_UP | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 4428_UP | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 5795_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 4649_UP | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 4082_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 3935_UP | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 2481_UP | |
| Drug | butamben | 1.99e-04 | 15 | 32 | 2 | CID000002482 | |
| Drug | pentasulfane | 2.27e-04 | 16 | 32 | 2 | CID000448216 | |
| Drug | decahydroisoquinoline | 2.27e-04 | 16 | 32 | 2 | CID000097812 | |
| Drug | efonidipine | 2.57e-04 | 17 | 32 | 2 | CID000119170 | |
| Drug | Zonisamide | 2.57e-04 | 17 | 32 | 2 | DB00909 | |
| Drug | N-methyl-DL-aspartic acid | 2.65e-04 | 655 | 32 | 6 | CID000004376 | |
| Drug | 1xa5 | 3.00e-04 | 93 | 32 | 3 | CID000157684 | |
| Drug | tetradotoxin | 3.04e-04 | 428 | 32 | 5 | CID000020382 | |
| Drug | glutamate | 3.13e-04 | 962 | 32 | 7 | CID000000611 | |
| Drug | cyclopropanecarboxylic acid | 3.22e-04 | 19 | 32 | 2 | CID000015655 | |
| Drug | nitrendipine | 3.50e-04 | 98 | 32 | 3 | CID000004507 | |
| Drug | AC1N8N2J | 3.58e-04 | 20 | 32 | 2 | CID004346372 | |
| Drug | R1C | 3.58e-04 | 20 | 32 | 2 | CID009961424 | |
| Drug | HCNs | 3.58e-04 | 20 | 32 | 2 | CID006857665 | |
| Drug | loperamide | 4.29e-04 | 105 | 32 | 3 | CID000003954 | |
| Drug | pyraclofos | 4.41e-04 | 106 | 32 | 3 | CID000093460 | |
| Drug | gamma-aminobutyric acid | 4.85e-04 | 474 | 32 | 5 | CID000000119 | |
| Drug | hydroxamates | 5.63e-04 | 25 | 32 | 2 | CID000033630 | |
| Drug | lamotrigine | 5.74e-04 | 116 | 32 | 3 | CID000003878 | |
| Drug | arabinosyladenine | 5.93e-04 | 762 | 32 | 6 | CID000000191 | |
| Drug | Pilocarpine | 6.56e-04 | 285 | 32 | 4 | ctd:D010862 | |
| Drug | rufinamide | 7.59e-04 | 29 | 32 | 2 | CID000129228 | |
| Drug | Linuron | 7.64e-04 | 128 | 32 | 3 | ctd:D008044 | |
| Drug | methyl cellosolve | 7.65e-04 | 297 | 32 | 4 | ctd:C005219 | |
| Drug | enzacamene | 7.82e-04 | 129 | 32 | 3 | ctd:C038939 | |
| Drug | AC1L1DXE | 7.84e-04 | 299 | 32 | 4 | CID000002548 | |
| Drug | aniracetam | 7.99e-04 | 130 | 32 | 3 | CID000002196 | |
| Drug | anacardic acid | 8.12e-04 | 30 | 32 | 2 | CID000167551 | |
| Drug | oxcarbazepine | 8.12e-04 | 30 | 32 | 2 | CID000034312 | |
| Drug | GYKI 53655 | 8.12e-04 | 30 | 32 | 2 | CID000126757 | |
| Drug | pyrachlostrobin | 8.22e-04 | 811 | 32 | 6 | ctd:C513428 | |
| Drug | Barium permanganate | 8.54e-04 | 133 | 32 | 3 | CID000024587 | |
| Drug | S-nitroso-N-acetyl-D,L-penicillamine | 8.73e-04 | 134 | 32 | 3 | CID000005231 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 8.76e-04 | 308 | 32 | 4 | CID000001915 | |
| Drug | SQ22536 | 8.92e-04 | 135 | 32 | 3 | CID000005270 | |
| Drug | willardine | 9.25e-04 | 32 | 32 | 2 | CID000005123 | |
| Drug | halothane | 9.41e-04 | 314 | 32 | 4 | CID000003562 | |
| Drug | octylmethoxycinnamate | 9.70e-04 | 139 | 32 | 3 | ctd:C118580 | |
| Disease | childhood absence epilepsy (is_implicated_in) | 3.18e-05 | 8 | 32 | 2 | DOID:1825 (is_implicated_in) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.69e-04 | 99 | 32 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Autistic Disorder | 1.77e-04 | 261 | 32 | 4 | C0004352 | |
| Disease | Manic Disorder | 2.70e-03 | 71 | 32 | 2 | C0024713 | |
| Disease | Alcoholic Intoxication, Chronic | 3.02e-03 | 268 | 32 | 3 | C0001973 | |
| Disease | Manic | 3.25e-03 | 78 | 32 | 2 | C0338831 | |
| Disease | Depression, Bipolar | 3.33e-03 | 79 | 32 | 2 | C0005587 | |
| Disease | Mechanical Allodynia | 3.76e-03 | 84 | 32 | 2 | C2936719 | |
| Disease | Hyperalgesia | 3.76e-03 | 84 | 32 | 2 | C0020429 | |
| Disease | Allodynia | 3.76e-03 | 84 | 32 | 2 | C0458247 | |
| Disease | Hyperalgesia, Secondary | 3.76e-03 | 84 | 32 | 2 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.76e-03 | 84 | 32 | 2 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.76e-03 | 84 | 32 | 2 | C0751214 | |
| Disease | Tactile Allodynia | 3.76e-03 | 84 | 32 | 2 | C0751213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YAMTSFHYTIMVTEA | 261 | O00574 | |
| MGMMTEYYHYFFTTL | 246 | P39086 | |
| TTMYALYITVHGYFL | 426 | Q86Y34 | |
| NMYTMSHYYDYPSIA | 306 | P05556 | |
| YTLEHMHAFGMYNYL | 51 | Q96RS6 | |
| GYYMYIEASHMVYGQ | 551 | Q7Z304 | |
| MMLFIGMYFTYSHLY | 201 | Q5VWC8 | |
| YTYVMEHLFRYMVGT | 231 | Q7Z465 | |
| YMMTLEDHYHSDVAY | 391 | Q07343 | |
| DHSMLYYYGQIHMYE | 1441 | P10070 | |
| YFVMEYVTGGDLMYH | 431 | P05129 | |
| MYEMLYGETPFYAES | 271 | Q9Y5S2 | |
| YEYHGTSSAMVMFEL | 191 | O75419 | |
| VTMNFGVHAIMYTYY | 171 | Q9HB03 | |
| EIMYYVMDAHSFYNF | 361 | Q9P0X4 | |
| TFYLSHREGYGTMYM | 51 | Q9P2S6 | |
| GMMTEYYHYIFTTLD | 246 | Q13002 | |
| PEYMVYMFKYDSTHG | 111 | O14556 | |
| VDIMYYVMDAHSFYN | 381 | O95180 | |
| DNMSYSVEVSYMEIY | 136 | Q12756 | |
| PESIMGYSYMDSYQT | 281 | O00482 | |
| SYDDLSHLYPYFNMM | 711 | A2RUB1 | |
| STVAAMYYSYYMLPD | 361 | Q12872 | |
| YMAYADYHDLMEITE | 341 | Q15046 | |
| HSLYTTYKDYEIMFH | 671 | O43166 | |
| GTHSLYTMYQDYEIM | 681 | O60292 | |
| YTMYQDYEIMFHVST | 686 | O60292 | |
| DMITYSCYSGYMLEG | 3436 | Q4LDE5 | |
| MYYSAEHGYVDITME | 721 | Q8N961 | |
| DYHDENMYYSQSSMF | 36 | Q9NZN8 | |
| SIHLYFDGMSLSYFM | 1336 | Q9BXT8 | |
| MAVAVFMEGFLFYYH | 121 | Q96B21 | |
| HYVMYYEMSYGLNIE | 66 | Q04727 |